{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:45:58Z","timestamp":1782902758257,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010023","name":"Natural Science Research of Jiangsu Higher Education Institutions of China","doi-asserted-by":"publisher","award":["22KJA320004"],"award-info":[{"award-number":["22KJA320004"]}],"id":[{"id":"10.13039\/501100010023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023\\u202FM732974"],"award-info":[{"award-number":["2023\\u202FM732974"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072814"],"award-info":[{"award-number":["82072814"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijbiomac.2024.138515","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T11:45:02Z","timestamp":1733485502000},"page":"138515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Co-immunization with IFI35 enhances the therapeutic effect of an adenovirus vaccine against renal carcinoma"],"prefix":"10.1016","volume":"286","author":[{"given":"Bowen","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leizi","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafei","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiage","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijbiomac.2024.138515_bb0005","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3390\/ijms21072532","article-title":"Immunotherapy in renal cell carcinoma: the future is now","volume":"21","author":"Deleuze","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.138515_bb0010","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138515_bb0015","doi-asserted-by":"crossref","first-page":"E154","DOI":"10.5489\/cuaj.4464","article-title":"Epidemiology of renal cancer in developing countries: review of the literature","volume":"12","author":"Medina-Rico","year":"2018","journal-title":"Can. Urol. Assoc. J."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.138515_bb0020","first-page":"507","article-title":"Treatment of renal cell carcinoma: current status and future directions","volume":"67","author":"Barata","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138515_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035938","article-title":"Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer","volume":"10","author":"Vasudev","year":"2020","journal-title":"BMJ. Open"},{"key":"10.1016\/j.ijbiomac.2024.138515_bb0030","doi-asserted-by":"crossref","first-page":"1133832","DOI":"10.3389\/fonc.2023.1133832","article-title":"Treatment strategies for clear cell renal cell carcinoma: past, present and future","volume":"13","author":"Yang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2024.138515_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118632","article-title":"Current updates and future perspectives on the management of renal cell carcinoma","volume":"264","author":"Singh","year":"2021","journal-title":"Life. Sci"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138515_bb0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.eururo.2021.02.025","article-title":"Predicting disease recurrence, early progression, and overall survival following surgical resection for high-risk localized and locally advanced renal cell carcinoma","volume":"80","author":"Correa","year":"2021","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138515_bb0045","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges, and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138515_bb0050","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/s41467-019-10594-2","article-title":"Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade","volume":"10","author":"D\u2019Alise","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.138515_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001812","article-title":"Next-generation vaccines: nanoparticle-mediated DNA and mRNA delivery","volume":"10","author":"Ho","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"23","key":"10.1016\/j.ijbiomac.2024.138515_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.168297","article-title":"DNA vaccines: history, molecular mechanisms and future perspectives","volume":"435","author":"Pagliari","year":"2023","journal-title":"J. Mol. Biol."},{"issue":"24","key":"10.1016\/j.ijbiomac.2024.138515_bb0065","doi-asserted-by":"crossref","first-page":"13225","DOI":"10.1002\/anie.202010282","article-title":"Biopolymer-based carriers for DNA vaccine design","volume":"60","author":"Franck","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ijbiomac.2024.138515_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omto.2021.11.017","article-title":"Dual-targeting vaccine of FGL1\/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity","volume":"24","author":"Chai","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138515_bb0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1158\/1535-7163.MCT-18-0832","article-title":"Combining DNA vaccine and AIM2 in H1 nanoparticles exert anti-renal carcinoma effects via enhancing tumor-specific multi-functional CD8(+) T-cell responses","volume":"18","author":"Chai","year":"2019","journal-title":"Mol. Cancer. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138515_bb0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41541-023-00706-x","article-title":"The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma","volume":"8","author":"Jiang","year":"2023","journal-title":"NPJ. Vaccines"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138515_bb0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12929-023-00930-6","article-title":"Tumor-secreted IFI35 promotes proliferation and cytotoxic activity of CD8(+) T cells through PI3K\/AKT\/mTOR signaling pathway in colorectal cancer","volume":"30","author":"Li","year":"2023","journal-title":"J. Biomed. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.138515_bb0090","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41418-024-01292-8","article-title":"IFI35 regulates non-canonical NF-kappaB signaling to maintain glioblastoma stem cells and recruit tumor-associated macrophages","volume":"31","author":"Li","year":"2024","journal-title":"Cell. Death. Differ."},{"key":"10.1016\/j.ijbiomac.2024.138515_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121137","article-title":"M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages","volume":"278","author":"Gunassekaran","year":"2021","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.138515_bb0100","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.3390\/cancers12082226","article-title":"Understanding the role of innate immune cells and identifying genes in breast Cancer microenvironment","volume":"12","author":"Shihab","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.138515_bb0105","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41388-023-02934-w","article-title":"IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion","volume":"43","author":"Xu","year":"2024","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.138515_bb0110","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.3390\/cancers14122861","article-title":"IFI35 promotes renal Cancer progression by inhibiting pSTAT1\/pSTAT6-dependent autophagy","volume":"14","author":"Chai","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2024.138515_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106034","article-title":"Adenovirus vaccine therapy with CD137L promotes CD8(+) DCs-mediated multifunctional CD8(+) T cell immunity and elicits potent anti-tumor activity","volume":"175","author":"Ding","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2024.138515_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101848","article-title":"Antigen cross-presentation by dendritic cells: a critical axis in cancer immunotherapy","volume":"71","author":"Moussion","year":"2024","journal-title":"Semin. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.138515_bb0125","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.1021\/acsnano.0c04188","article-title":"Enhanced Cancer DNA vaccine via direct transfection to host dendritic cells recruited in injectable scaffolds","volume":"14","author":"Nguyen","year":"2020","journal-title":"ACS. Nano."},{"issue":"23","key":"10.1016\/j.ijbiomac.2024.138515_bb0130","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.7150\/jca.34471","article-title":"Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated tumor cell killing in glioma cells","volume":"10","author":"Sun","year":"2019","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138515_bb0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s40425-018-0399-6","article-title":"Resident memory T cells, critical components in tumor immunology","volume":"6","author":"Mami-Chouaib","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.138515_bb0140","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s13238-020-00707-9","article-title":"Memory T cells: strategies for optimizing tumor immunotherapy","volume":"11","author":"Liu","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.ijbiomac.2024.138515_bb0145","first-page":"136","article-title":"Cancer nanomedicine in preoperative therapeutics: nanotechnology-enabled neoadjuvant chemotherapy, radiotherapy, immunotherapy, and phototherapy","volume":"24","author":"Qu","year":"2023","journal-title":"Bioact. Mater."},{"issue":"46","key":"10.1016\/j.ijbiomac.2024.138515_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202107946","article-title":"Recent advances in delivery Systems for Genetic and Other Novel Vaccines","volume":"34","author":"Huang","year":"2022","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.138515_bb0155","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3390\/cancers13081863","article-title":"Nonreplicating adenoviral vectors: improving tropism and delivery of Cancer gene therapy","volume":"13","author":"Tessarollo","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138515_bb0160","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/cancers12051295","article-title":"Adenovirus and immunotherapy: advancing Cancer treatment by combination","volume":"12","author":"Sato-Dahlman","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138515_bb0165","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","article-title":"Roles of natural killer cells in immunity to cancer, and applications to immunotherapy","volume":"23","author":"Wolf","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138515_bb0170","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.138515_bb0175","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.trecan.2021.06.007","article-title":"Immunity beyond cancer cells: perspective from tumor tissue","volume":"7","author":"Gao","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ijbiomac.2024.138515_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106939","article-title":"Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment","volume":"88","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.138515_bb0185","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.immuni.2021.11.015","article-title":"Cytotoxic CD4(+) T cells in cancer: expanding the immune effector toolbox","volume":"54","author":"Oh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2024.138515_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101481","article-title":"The role of dendritic cells in cancer and anti-tumor immunity","volume":"52","author":"Marciscano","year":"2021","journal-title":"Semin. Immunol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.138515_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110111","article-title":"Inflammatory macrophages exploit unconventional pro-phagocytic integrins for phagocytosis and anti-tumor immunity","volume":"37","author":"Tang","year":"2021","journal-title":"Cell. Rep."},{"key":"10.1016\/j.ijbiomac.2024.138515_bb0200","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.3389\/fimmu.2018.03176","article-title":"Human dendritic cells: their heterogeneity and clinical application potential in Cancer immunotherapy","volume":"9","author":"Patente","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138515_bb0205","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.138515_bb0210","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3389\/fimmu.2019.00741","article-title":"Langerin(+)CD8(+) dendritic cells in the splenic marginal zone: not so marginal after all","volume":"10","author":"Backer","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.138515_bb0215","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","article-title":"Expansion and activation of CD103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition","volume":"44","author":"Salmon","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2024.138515_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101710","article-title":"MHC-dressing on dendritic cells: boosting anti-tumor immunity via unconventional tumor antigen presentation","volume":"66","author":"Chatterjee","year":"2023","journal-title":"Semin. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138515_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188763","article-title":"The performance and perspectives of dendritic cell vaccines modified by immune checkpoint inhibitors or stimulants","volume":"1877","author":"Ding","year":"2022","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.138515_bb0230","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005967","article-title":"Apoptosis: a Janus bifrons in T-cell immunotherapy","volume":"11","author":"Lee","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"7967","key":"10.1016\/j.ijbiomac.2024.138515_bb0235","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","article-title":"CD4(+) T cell-induced inflammatory cell death controls immune-evasive tumours","volume":"618","author":"Kruse","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.138515_bb0240","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jconrel.2023.05.044","article-title":"Dying tumor cells-inspired vaccine for boosting humoral and cellular immunity against cancer","volume":"359","author":"Qin","year":"2023","journal-title":"J. Control. Release"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024093267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024093267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:04:48Z","timestamp":1782900288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024093267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":48,"alternative-id":["S0141813024093267"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138515","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-immunization with IFI35 enhances the therapeutic effect of an adenovirus vaccine against renal carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"138515"}}